The Benchmark Company acted as a Co-Manager of MTBC’s Largest Public Offering of Non-Convertible Preferred Stock with $20.7 Million in Gross Proceeds.
The Benchmark Company Announces Closing of Public Offering of $5.0 Million for Hoth Therapeutics, Inc.
The Benchmark Company Expands Its Biotechnology Focus With The Addition Of Dr. Aydin Huseynov And Dr. Okechukwu Linton
The Benchmark Company Announces Closing of Public Offering of $4.5m for Seelos Therapeutics, Inc.
Benchmark Managing Director and Internet & Media Analyst Daniel Kurnos, CFA, Preview’s Amazon’s Amazing 4Q Results
Benchmark Managing Director and Internet & Media Analyst Daniel Kurnos, CFA, Serves up 6 Minutes of Food Delivery Commentary on CNBC
The Benchmark Company Adds Industrial Research Team To Its Growing Platform
8th Annual Discovery 1×1 Conference
Edward Rubin Joins Benchmark as Co-Head of Investment Banking
